Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZX100 for scar prevention in arthroscopic shoulder surgery
NCT00811577Phase 2Completed
- Sponsor
- OrthoLogic Corp.
- Start
- Jan 2009
- Primary completion
- Dec 2010
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of azx-100 in surgical scar, sponsored by OrthoLogic Corp.. Started Jan 2009; status: completed.
02
Drugs
azx-100
03
Conditions
surgical scar
Beyond the preview
Go deeper on NCT00811577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811577.